LWLingfei Wei

Lingfei Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lingfei Wei has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Yufeng Zhang

    The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China

    7 shared publications
  • Richard J. Miron

    The State Key Laboratory Breeding Base of Basic Science of Stomatology & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China

    5 shared publications
  • Yuelian Liu

    4 shared publications
  • Yuelian Liu

    Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam and University of Amsterdam, Amsterdam Movement Sciences, 1081 LA Amsterdam, The Netherlands

    4 shared publications
  • Zhonghao Liu

    4 shared publications
  • Dedong Yu

    3 shared publications

Latest Publications

  • Open Access

    Alveolar Ridge Preservation Using Low Dosage Bone Morphogenetic Protein 2 Incorporated Biomimetic Calcium Phosphate

    by Wenjing Zhang, Jie Liang, Dedong Yu, Zhonghao Liu, Yuelian Liu, Lingfei Wei


    • 18 July 2026
      • Vol. 76  (5) , 109731

    Alveolar Ridge Preservation Using Low Dosage Bone Morphogenetic Protein 2 Incorporated Biomimetic Calcium Phosphate.

    by Wenjing Zhang, Jie Liang, Dedong Yu, Zhonghao Liu, Yuelian Liu, Lingfei Wei

    To evaluate the efficacy of low dosage bone morphogenetic protein 2 incorporated biomimetic calcium phosphate (BMP-2/BioCaP) combined with a collagen matrix for alveolar ridge preservation in canine extraction sockets. Distal roots of mandibular premolars were atraumatically extracted from six dogs. The extraction sockets were randomly assigned to one of the following groups: (a) no graft (blank control), (b) deproteinised bovine bone matrix (DBBM), (c) biomimetic calcium phosphate (BioCaP), and (d) BMP-2/BioCaP. Groups (b) to (d) were covered with a collagen matrix. Cone-beam computed tomography (CBCT) scans were obtained immediately after surgery and at 12 weeks postoperatively. The images were superimposed to assess vertical and horizontal ridge dimensional changes. After euthanasia, the specimens were subjected to microcomputed tomography (micro-CT) and histomorphometric analyses. CBCT analyses revealed significantly less buccal height and ridge width loss in the BMP-2/BioCaP and DBBM groups compared with the control. Micro-CT demonstrated greater bone mineral density, bone volume fraction, and trabecular number in the BMP-2/BioCaP group. Histological evaluation confirmed significantly higher new bone volume density in the BMP-2/BioCaP group compared with DBBM and BioCaP. Nonmineralised tissue volume density was significantly reduced in the BMP-2/BioCaP group compared with the control and BioCaP. BMP-2/BioCaP combined with a collagen matrix effectively preserves alveolar ridge dimensions and enhances new bone formation, indicating its promise as a bone substitute for clinical ridge preservation. BMP-2/BioCaP demonstrated improved ridge preservation and bone regeneration compared with natural healing in this animal model, suggesting its potential as a feasible strategy for alveolar ridge preservation.

  • Open Access

    Dental Brace Register for Accurate and Reproducible Bone Augmentation Evaluation in Dental Implantology

    by Jiayuan Zhang, Zhifan Sun, Xuemei Xie, Lingfei Wei, Chunfeng Xu, Dedong Yu

    Accurate evaluation of bone augmentation is essential for surgical planning in dental implantology, and it is also crucial for validating the efficiency of bone augmentation approaches. However, the prevailing evaluation methods are complicated, time-consuming, operator-dependent, and hardly reproducible, undermining their feasibility and reliability in clinic. In response to these limitations, a registration apparatus composed of a transparent orthodontic retainer and radiographic markers was developed, enabling image superimposition before and after bone augmentation. A mandibular specimen underwent cone beam computed tomography (CBCT) scans at baseline, three, and six months, with and without the apparatus. Image registrations were independently performed by two examiners using the registration apparatus and two alternative methods. Root mean square (RMS) deviations were calculated to quantify registration accuracy. Statistical analyses were conducted using ANOVA and paired t-tests. Significant differences in RMS deviations were observed between the registration methods (p = 0.002), and using the registration apparatus achieved the lowest RMS deviation (0.055 ± 0.030 mm) and consistency at different timepoints (p = 0.856) and examiners (p = 0.441). This registration apparatus demonstrated high accuracy and reproducibility in bone augmentation evaluation, making it a potential reliable tool for quantitative evaluation of bone augmentation in dental implantology.

  • Open Access

    Harnessing strontium in regenerative dentistry: progress and perspectives

    by Wenjing Zhang, Lingfei Wei

    Strontium (Sr), an alkaline earth element characterized by its unique bioactivity, has garnered significant interest in the field of oral regenerative medicine. This interest is primarily due to its inherent presence in bone tissues, particularly in growth plates and trabeculae, and its ability to influence bone metabolism through the calcium-sensing receptor (CaSR). Various signaling pathways, including MAPK/ERK1/2 and Wnt/NFATc, are involved in the mechanisms behind these effects. Strontium-doped biomaterials progressively release Sr 2+ ions, which impart a variety of biological effects, among these are the stimulation of osteoblast proliferation and differentiation, and the exhibition of antibacterial and anti-inflammatory characteristics. Moreover, these ions are involved in regulating the deposition of the extracellular matrix. Collectively, these characteristics underscore the potential utility of strontium-doped biomaterials for the regeneration of soft and hard tissues, exemplified by applications in alveolar bone reconstruction and the osseointegration of dental implants. Despite these advantages, numerous challenges persist, particularly in relation to degradation kinetics, long-term in vivo stability, and translational applications. This review offers a comprehensive examination of the biological roles of strontium, recent advancements in its integration into biomaterials, and the underlying molecular mechanisms. Additionally, it addresses current limitations and proposes potential strategies for optimization, thus offering a theoretical basis for the future creation of novel oral regenerative materials.


  • Open Access

    The Clinical Efficacy and Safety of ErhBMP‐2/BioCaP/β‐TCP as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial

    by Lingfei Wei, Yuanyuan Sun, Dedong Yu, Herman Pieterse, Daniel Wismeijer, Yuelian Liu, Yiqun Wu

    Aim: This first randomized controlled trial in humans aimed to assess the efficacy and safety of low‐dosage Escherichia coli‐derived recombinant human bone morphogenetic protein 2 (ErhBMP‐2)‐incorporated biomimetic calcium phosphate coating‐functionalized β‐TCP (ErhBMP‐2/BioCaP/β‐TCP) as a novel bone substitute using the tooth‐extraction‐socket‐healing model.Materials and Methods: Forty patients requiring dental implants after single‐root tooth extraction were enrolled in this study and randomly assigned into three groups: ErhBMP‐2/BioCaP/β‐TCP (N = 15), β‐TCP (N = 15) and natural healing (N = 10). New bone volume density from histomorphometric analyses was evaluated 6 weeks post‐operatively as the primary outcome, and other histomorphometric analyses, alveolar bone and soft‐tissue changes were the secondary outcomes. Safety parameters included adverse events, soft‐tissue healing, oral health impact profile, serum BMP‐2 concentrations and other laboratory tests.Results: The findings revealed a significant increase in new bone volume density in patients treated with ErhBMP‐2/BioCaP/β‐TCP compared to those receiving β‐TCP alone. The required bone augmentation procedures during implant placement surgery in the ErhBMP‐2/BioCaP/β‐TCP group were significantly less than in the natural healing group. There were no significant differences in safety parameters among the three groups.Conclusion: This clinical trial primarily proved the safety and efficacy of ErhBMP‐2/BioCaP/β‐TCP as a promising bone substitute.


  • Calcium Phosphate Ceramics and Synergistic Bioactive Agents for Osteogenesis in Implant Dentistry

    by Chunfeng Xu, Yuanyuan Sun, John Jansen, Menghong Li, Lingfei Wei, Yiqun Wu, Yuelian Liu

    Implant-supported dental prosthetics are widely used in dental practice. Sufficient peri-implant bone tissue is a crucial prerequisite for the long-term success of this treatment, as insufficient peri-implant bone volume hampers dental implant installation and negatively influences dental implant stability. However, due to tooth extraction, bone metabolism diseases, and trauma, bone defects in the jaw are common in patients, particularly in the elderly and those suffering from underlying conditions. If this is the case, alveolar ridge has to be augmented for reliable implant placement. Various biomaterials, growth factors or growth factor-based products, and trace elements have been tested and used for alveolar ridge augmentation. Among those biomaterials, calcium phosphates (CaPs) are the most popular due to their promising biocompatibility, great osteoconductivity, and distinguishing osteogenesis. Combining CaPs with growth factors or trace elements can further favor bone defect repair. This review mainly focuses on applying artificial CaP biomaterials and their combination with bioactive agents to repair bone defects in implant dentistry.


  • Open Access

    Coralline Hydroxyapatite Coated with a Layer Biomimetic Calcium Phosphate Containing BMP-2 Induces Dose-Related Ectopic Bone Formation in Wistar Rats

    by Henri J. J. Uijlenbroek, Xingnan Lin, Xin Zhang, Liquan Deng, Daniel Wismeijer, Mingjie Wang, Lingfei Wei, Yuanna Zheng, Yuelian Liu

    In order to evaluate loading methods and the dose dependency of bone morphogenetic protein 2 (BMP-2) in ectopic bone formation, an osteoinductive material consisting of commercially available coralline hydroxyapatite (CHA) was coated with a layer of biomimetic calcium phosphate (BioCaP) containing BMP-2 in different ways. Eight groups—each containing samples of 0.25 g CHA—were formed and coated with, respectively, BioCaP with internally incorporated BMP-2 in concentrations of 1, 5, 10, 20, 40 and 60 µg per sample, and the two control groups with BioCaP only and BioCaP with 20 µg of adsorbed BMP-2 per sample. The samples were implanted subcutaneously in 27 male Wistar rats. The histological results show that there is no bone formation in the group in which no BMP-2 was included. All samples with BioCaP containing BMP-2 show bone formation. The group with 20 µg of adsorbed BMP-2 per sample shows the least bone formation. Coating-incorporated BMP-2 is more efficient in inducing bone formation than adsorbed BMP-2. The group with 5 µg of coating-incorporated BMP-2 per sample shows the most bone formation. Increasing the amount of coating-incorporated BMP-2 up to 60 µg does not improve ectopic bone formation.


  • Open Access

    Periodontal regeneration using bone morphogenetic protein 2 incorporated biomimetic calcium phosphate in conjunction with barrier membrane: A pre‐clinical study in dogs

    by Lingfei Wei, Fei Teng, Liquan Deng, Gangfeng Liu, Mengyin Luan, Jie Jiang, Zhonghao Liu, Yuelian Liu

    Aim: To evaluate the effect of bone morphogenetic protein 2 (BMP‐2) incorporated biomimetic calcium phosphate (BMP‐2/BioCaP) in conjunction with barrier membrane on periodontal regeneration in chronic periodontitis experimental model.Material and Methods: Chronic periodontitis experimental model with critical‐sized supra‐alveolar defects was created in 15 dogs’ mandibles. After the initial periodontal therapy, the defects were randomly assigned to the following groups: (a) control; (b) barrier membrane; (c) deproteinized bovine bone mineral + barrier membrane; (d) BioCaP + barrier membrane and (e) BMP‐2/BioCaP + barrier membrane (6 quadrants with 18 teeth per group). Eight weeks later, clinical examinations, micro‐CT, and histomorphometric analyses were performed.Results: Clinical examinations, including plaque index, bleeding index, and probing depth, were similar for all groups. In contrast, the clinical attachment loss was significantly lower in defects grafted with BMP‐2/BioCaP and barrier membrane. The micro‐CT results showed that the height of mineralized tissue in defects grafted with BMP‐2/BioCaP and barrier membrane was significantly higher. For histometric analysis, the defects grafted with BMP‐2/BioCaP and barrier membrane exhibited significantly more connective tissue height, new cementum height, new bone height and area, as well as less down‐growth of junctional epithelium.Conclusion: BMP‐2/BioCaP could be a promising bone substitute for periodontal regeneration.